Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.03.29
关于举行2010年度业绩网上说明会的通告
2011.03.28
2010年度财务决算报告
2011.03.28
关于2010年度关联生意执行情形及2011年预计关联生意事项的通告
2011.03.28
第二届监事会第二次聚会决议通告
2011.03.28
2010年年度审计报告
2011.03.28
第二届董事会第二次聚会决议通告
2011.03.28
董事、监事和高级治理职员薪酬与绩效审核制度(2011年3月)
2011.03.28
关于开展2011年远期外汇生意情形的通告
2011.03.28
关于公司2010年度召募资金存放与使用情形的鉴证报告
2011.03.28
董事会2010年度内部控制自我评价报告
第一页
上一页
139
140
141
142
143
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】